ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nael Martini
Edward J. Beattie, Jr.
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilaris, B. S.
Right arrow Articles by Beattie, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilaris, B. S.
Right arrow Articles by Beattie, E. J., Jr.

Ann Thorac Surg 1975;20:491-500
© 1975 The Society of Thoracic Surgeons

Articles

Interstitial Irradiation for Unresectable Carcinoma of the Lung

Basil S. Hilaris, M.D.*, Nael Martini, M.D., Mostafa Batata, M.D., Edward J. Beattie, Jr., M.D.

Departments of Radiation Therapy and Surgery, Memorial Sloan-Kettering Cancer Center, New York, N.Y.

* Address reprint requests to Dr. Hilaris, Department of Radiation Therapy, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, N.Y. 10021

From 1963 to 1971, 105 patients with histologically proved cancer of the lung were explored at Memorial Hospital and underwent interstitial implantation using encapsulated sources of radon 222 (53 patients) or iodine 125 (52 patients). These lung cancers were considered unresectable because of extension of the disease into the mediastinum with fixation or invasion of the major vessels, trachea, and esophagus or chest wall involvement. No apical lesions, which have a better prognosis, are included in this review. Sixty-nine patients had epidermoid cancer, 24 had adenocarcinoma, and the remaining 12 had various other histological types. All patients were staged according to the criteria proposed by the American Joint Committee using the TNM definitions (standing for tumor, nodes, and metastasis).

Local control was obtained in 8 of 10 patients (80% with clinical Stage I and II unresectable cancers of the lung and in 44 of the 95 (46%) with clinical Stage III lung cancer. The two-year survival was 50% for Stages I and II and 7% for Stage III. Five patients have survived for five years or more. The complications, disease-free interval, local recurrences, distant metastases, and survival are presented and indications for this type of therapy outlined.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
B. O. Anderson and M. E. Burt
Chest wall neoplasms and their management
Ann. Thorac. Surg., December 1, 1994; 58(6): 1774 - 1781.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. W. Lewis Jr, M. Ajlouni, P. A. Kvale, N. Groux, Y. Bae, B. S. Horowitz, and D. J. Magilligan Jr
Role of brachytherapy in the management of pulmonary and mediastinal malignancies
Ann. Thorac. Surg., May 1, 1990; 49(5): 728 - 733.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. B. Skinner
Technical and scientific advances in general thoracic surgery
Ann. Thorac. Surg., January 1, 1990; 49(1): 14 - 25.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
P. McCormack, M. S. Bains, E. J. Beattie Jr., and N. Martini
New Trends in Skeletal Reconstruction after Resection of Chest Wall Tumors
Ann. Thorac. Surg., January 1, 1981; 31(1): 45 - 52.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The Society of Thoracic Surgeons.